Juvenile absence epilepsy exacerbated by valproic acid

被引:10
|
作者
Buechler, Robbie D. [1 ]
Buchhalter, Jeffrey R. [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
关键词
D O I
10.1016/j.pediatrneurol.2006.08.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Valproic acid is commonly and effectively used in the treatment of idiopathic generalized epilepsies, including juvenile absence epilepsy. Although several adverse effects are associated with this drug, it has only rarely been known to exacerbate seizures. Similar to antiarrhythmic drugs aggravating particular arrhythmias, antiepileptic drugs can paradoxically induce new seizure types or exacerbate existing ones. This reaction is better known with carbamazepine and phenytoin, but is less common with broad-spectrum antiepileptic drugs such as valproic acid. This report describes a case of paradoxical, intravenous valproic acid-induced seizure exacerbation in a child with juvenile absence epilepsy, documented by video-electroencephalography. (c) 2007 by Elsevier Inc. All rights reserved.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 50 条
  • [1] Alternatives to valproic acid in juvenile myoclonic epilepsy
    Kuzmanovski, I.
    Cvetkovska, E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S255 - S256
  • [2] Characteristics of valproic acid resistant juvenile myoclonic epilepsy
    Fernando-Dongas, MC
    Radtke, RA
    Vanlandingham, KE
    Husain, AM
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2000, 9 (06): : 385 - 388
  • [3] Risk factors for valproic acid resistance in childhood absence epilepsy
    Ollivier, May Lissa
    Dubois, Marie France
    Krajinovic, Maja
    Cossette, Patrick
    Carmant, Lionel
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2009, 18 (10): : 690 - 694
  • [4] Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy.
    Glauser, Tracy A.
    Cnaan, Avital
    Shinnar, Shlomo
    Hirtz, Deborah G.
    Dlugos, Dennis
    Masur, David
    Clark, Peggy O.
    Capparelli, Edmund V.
    Adamson, Peter C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (09): : 790 - 799
  • [5] Pharmacokinetics of valproic acid in patients with juvenile myoclonic epilepsy on monotherapy
    Sundqvist, A
    Tomson, T
    Lundkvist, B
    THERAPEUTIC DRUG MONITORING, 1997, 19 (02) : 153 - 159
  • [6] Absence Seizures of Epilepsy of Children Ethosuximide before Valproic Acid and Lamotrigine
    Ecker-Schlipf, Barbara
    PSYCHOPHARMAKOTHERAPIE, 2010, 17 (03): : 156 - 157
  • [7] VALPROIC ACID IN EPILEPSY
    LIVINGSTON, S
    PAULI, LL
    PRUCE, I
    KRAMER, II
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (18): : 1892 - 1892
  • [8] VALPROIC ACID IN EPILEPSY
    BERMAN, W
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (05): : 431 - 431
  • [9] RISK FACTORS FOR VALPROIC ACID NON-RESPONSE IN CHILDHOOD ABSENCE EPILEPSY
    Ollivier, May L.
    Dubois, Marie-France
    Cossette, P.
    Krajinovic, M.
    Carmant, Lionel
    EPILEPSIA, 2008, 49 : 91 - 92
  • [10] Factors associated with lack of response to valproic acid monotherapy in juvenile myoclonic epilepsy
    Jayalakshmi, Sita
    Vooturi, Sudhindra
    Bana, Ashok Kumar
    Sailaja, Sarva
    Somayajula, Shanmukhi
    Mohandas, Surath
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2014, 23 (07): : 527 - 532